Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory

Comparably Awards

Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions read more

This company is accepting feedback from verified employees EMPLOYEE PARTICIPANTS: 90

TOTAL RATINGS: 2628

CEO: Richard Paulson

Karyopharm Therapeutics Awards 2021

Karyopharm Therapeutics won 4 awards in 2021 and 4 awards in 2020. In 2021, Karyopharm Therapeutics won for Best Company Culture 2021, Best Places to Work in Boston 2021, Best Leadership Teams 2021 and Best Company Compensation. In 2020, Karyopharm Therapeutics won for Best Company Compensation, Best Company Happiness, Best Professional Development 2020 and Best Leadership Teams 2020. Based on 2,628 ratings and 90 participants, employees at Karyopharm Therapeutics are very satisfied with their work experience. The overall culture score, 79/100 or A-, incorporates employee ratings based on their feedback on the Compensation, Leadership, Diversity and more.

Awards

Comparably Awards are provided yearly to top performing company cultures based on real feedback from their employees.

Best Company Culture 2021 (Small & Midsize Companies)
Karyopharm Therapeutics
Best Company Culture 2021
Best Places to Work in Boston 2021
Karyopharm Therapeutics
Best Places to Work in Boston 2021
Best Leadership Teams 2021 (Small & Midsize Companies)
Karyopharm Therapeutics
Best Leadership Teams 2021
Best Company Compensation 2021 (Small & Midsize Companies)
Karyopharm Therapeutics
Best Company Compensation